FDA Clearance Tracker · P190018-S046
Clareon Vivity Toric Extended Vision UV Absorbing Hydrophobic Intraocular Lens (IOL)
Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this decision)Source: openFDAMethods & limitations
Decided
May 15, 2026
Approved
Time to decision
186 days
Received Nov 10, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P190018-S046
- Device name
- Clareon Vivity Toric Extended Vision UV Absorbing Hydrophobic Intraocular Lens (IOL)
- Applicant
- Alcon Laboratories, LLC
- Applicant location
- Fort Worth, TX
- Received
- Nov 10, 2025
- Decided
- May 15, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P190018
Device type
- Device type
- intraocular lens (HQL)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
approval for expanding the range for Clareon Vivity Toric Extended Vision UV Absorbing Hydrophobic IOLs in the lens case configuration to include 4.50 D (CNWET7/CCWET7), 5.25 D (CNWET8/CCWET8), and 6.0 D (CNWET9/CCWET9) cylindrical power models.
Source documents
Other decisions for Alcon Laboratories, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P190018 · Decided Jan 7, 2020 · 180 days after receipt
Device type: intraocular lens (HQL) · Ophthalmology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.